A STUDY OF HERCEPTIN (TRASTUZUMAB) IN COMBINATION WITH CISPLATIN/CAPECITABINE CHEMOTHERAPY IN PARTICIPANTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE METASTATIC GASTRIC OR GASTRO-ESOPHAGEAL JUNCTION CANCER: